Outsourced Pharma White Papers
-
Advancing Nanomedicine Production With Flow Manufacturing
5/6/2026
Learn how flow manufacturing enables scalable, reproducible nanomedicine production with tighter control, consistent particle quality, and smooth lab-to-commercial scaleāup.
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges
10/16/2024
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Operational Success By Strategic Investment
1/22/2026
Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.
-
Assessing A Targeted Molecular Method Against Traditional In Vitro Testing For Adventitious Virus Detection
10/3/2024
Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.
-
Process Development For Lyophilized Products
10/16/2024
Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.
-
Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies
12/29/2025
Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.
-
Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-Up
1/22/2026
In today’s fast-moving biopharma landscape, scaling from clinic to commercial takes more than expertise. See how collaboration can transform scale-up and drive confident progress
-
Advancements In Microbial Manufacturing Of Biopharmaceuticals
9/26/2024
Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.
-
FIH: Reach Milestones Sooner With A Technology-Driven Approach
2/12/2026
Accelerate your path to IND and FiH with AI-driven design, advanced cell line engineering, and intensified processes delivering high titers in 9–14 months.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products
10/16/2024
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.